Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Complete response for Delcath's Melblez Kit

FDA issued a complete response letter for an NDA for Melblez Kit chemosaturation system from Delcath

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE